iPath Series B Bloomberg Cotton Subindex Total Return ETN BAL
Set alert
61.00 USD 0.00 0.00%
As of Jun 8, 9:55 AM ET
59.85 Day range 61.00
52-week range unavailable
- Open
- 59.85
- Prev close
- 61.00
- Mkt cap
- 4.79M
- Vol
- 1.03K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 59.85
- High
- 61.00
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 60.90
- 200-d avg
- 59.46
2Y chart
Signals (93)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jun 1, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | May 26, 2023 | 3 years ago |
| SMA: Bearish | May 25, 2023 | 3 years ago |
| MACD: Sell Signal | May 25, 2023 | 3 years ago |
| SMA: Bearish | May 23, 2023 | 3 years ago |
| SMA: Bullish | May 17, 2023 | 3 years ago |
| SMA: Bullish | May 15, 2023 | 3 years ago |
| MACD: Buy Signal | May 15, 2023 | 3 years ago |
| MACD: Sell Signal | May 11, 2023 | 3 years ago |
| SMA: Bearish | May 9, 2023 | 3 years ago |
| MACD: Buy Signal | May 5, 2023 | 3 years ago |
| SMA: Bullish | May 4, 2023 | 3 years ago |
| SMA: Bearish | May 2, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 21, 2023 | 3 years ago |
| SMA: Bearish | Apr 20, 2023 | 3 years ago |
| SMA: Bullish | Apr 6, 2023 | 3 years ago |
| SMA: Bearish | Mar 31, 2023 | 3 years ago |
| SMA: Bullish | Mar 30, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 28, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 8, 2023 | 3 years ago |
| SMA: Bearish | Mar 7, 2023 | 3 years ago |
| SMA: Bullish | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Mar 2, 2023 | 3 years ago |
| SMA: Bullish | Mar 1, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Feb 28, 2023 | 3 years ago |
| SMA: Bullish | Feb 24, 2023 | 3 years ago |
| SMA: Bearish | Feb 15, 2023 | 3 years ago |
| SMA: Bullish | Feb 7, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 3, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 20, 2023 | 3 years ago |
| SMA: Bullish | Jan 18, 2023 | 3 years ago |
| SMA: Bearish | Jan 12, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 12, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 5, 2023 | 3 years ago |
| SMA: Bearish | Jan 4, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 30, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 19, 2022 | 3 years ago |
| SMA: Bullish | Dec 13, 2022 | 3 years ago |
| SMA: Bearish | Dec 8, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 8, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Nov 30, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 25, 2022 | 3 years ago |
| SMA: Bearish | Nov 18, 2022 | 3 years ago |
| SMA: Bullish | Nov 15, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 1, 2022 | 4 years ago |
| RSI: Oversold | Oct 28, 2022 | 4 years ago |
| RSI: Oversold | Oct 20, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 19, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 11, 2022 | 4 years ago |
| RSI: Oversold | Sep 29, 2022 | 4 years ago |
| SMA: Bearish | Sep 16, 2022 | 4 years ago |
| SMA: Bearish | Sep 13, 2022 | 4 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Sep 2, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 1, 2022 | 4 years ago |
| RSI: Overbought | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 11, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 18, 2022 | 4 years ago |
| RSI: Oversold | Jul 14, 2022 | 4 years ago |
| RSI: Oversold | Jul 6, 2022 | 4 years ago |
| RSI: Oversold | Jun 23, 2022 | 4 years ago |
| SMA: Bearish | Jun 14, 2022 | 4 years ago |
| SMA: Bullish | Jun 9, 2022 | 4 years ago |
| SMA: Bearish | Jun 7, 2022 | 4 years ago |
| SMA: Bullish | Jun 6, 2022 | 4 years ago |
| SMA: Bearish | Jun 1, 2022 | 4 years ago |
| SMA: Bullish | May 31, 2022 | 4 years ago |
| SMA: Bearish | May 27, 2022 | 4 years ago |
| MACD: Sell Signal | May 18, 2022 | 4 years ago |
| MACD: Buy Signal | May 16, 2022 | 4 years ago |
| MACD: Sell Signal | May 10, 2022 | 4 years ago |
| RSI: Overbought | May 4, 2022 | 4 years ago |
| MACD: Buy Signal | Apr 28, 2022 | 4 years ago |
| RSI: Overbought | Apr 28, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 21, 2022 | 4 years ago |
| MACD: Buy Signal | Apr 13, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 7, 2022 | 4 years ago |
| RSI: Overbought | Mar 24, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 17, 2022 | 4 years ago |
| SMA: Bullish | Mar 16, 2022 | 4 years ago |
| SMA: Bearish | Mar 14, 2022 | 4 years ago |
| SMA: Bullish | Mar 11, 2022 | 4 years ago |
| SMA: Bearish | Mar 4, 2022 | 4 years ago |
| MACD: Sell Signal | Feb 9, 2022 | 4 years ago |
| RSI: Overbought | Feb 3, 2022 | 4 years ago |
| RSI: Overbought | Jan 31, 2022 | 4 years ago |
| RSI: Overbought | Jan 18, 2022 | 4 years ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 60.90
- 200-day average
- 59.46
About iPath Series B Bloomberg Cotton Subindex Total Return ETN
The ETN offers exposure to futures contracts and not direct exposure to the physical commodities. The index is composed of one or more futures contracts on the relevant commodity (the “index components”) and is intended to reflect the returns that are potentially available through (1) an unleveraged investment in those contracts plus (2) the rate of interest that could be earned on cash collateral invested in specified Treasury Bills.
News
- Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
- Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
- Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026
- Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
- Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer
- Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026
- Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
- Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
- Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
- MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
Your note
Sign in to keep a note on BAL — it syncs with the Stock Master app.